Risa Lavizzo Mourey - Oct 28, 2021 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Director
Signature
/s/ Mark Heinen, Attorney-in-Fact for Risa J. Lavizzo-Mourey
Stock symbol
BTTX
Transactions as of
Oct 28, 2021
Transactions value $
$0
Form type
4
Date filed
11/1/2021, 08:55 PM
Previous filing
Oct 26, 2021
Next filing
Dec 23, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTTX Stock Option (Right to Buy) Award $0 +28.3K $0.00 28.3K Oct 28, 2021 Common Stock 28.3K $10.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Following the Issuer's filing of Form S-8 to register the shares subject to the stock option, the stock option vests as to 1/3 of the shares subject to the stock option on October 28, 2022 and the remaining shares vest in 24 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on October 28, 2021.